Vaxcyte (PCVX) Financials: Revenue & Earnings

PCVX price $61.21 +0.54 +0.89%

Ticker
PCVX
Price
$61.21
Change
+0.54 +0.89%
Market cap ?
$9.63B
P/E ?
-7.85
Forward P/E ?
82.35
Dividend yield ?
0.00%
Beta ?
1.23
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
58
Quality
46
Growth
100

Stocklytics score rationale: value 58, quality 46, growth 100.

Financials

201720182019202020212022202320242025
000000000

Vaxcyte, Inc. is a biotechnology firm in the clinical development stage, dedicated to creating innovative protein-based vaccines. Its primary objective is to either prevent or manage bacterial infectious diseases. The company's leading vaccine candidate is VAX-24, an experimental 24-valent pneumococcal conjugate vaccine currently undergoing Phase 1/2 clinical trials, intended to address invasive pneumococcal disease…

Fair value

PCVX fair value $29.20. Price $61.21. Price is 110% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare PCVX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-03—-2.11—12.50M
2026-08-05-1.97-2.06—12.50M
2026-05-06-2.30-1.78—12.50M
2026-02-24-1.80-1.53—18.75M
2025-11-04-1.56-1.27——
2025-08-06-1.22-1.12——
2025-05-07-1.04-1.02——
2025-02-25-1.02-1.16——
2024-11-05-0.83-1.10——
2024-08-06-1.10-0.98——
2024-05-08-0.85-1.13——
2024-02-27-1.82-0.9014.45M—
2023-11-06-0.91-0.79——
2023-08-08-0.70-0.67——
2023-05-08-0.70-0.80——
2023-02-27-0.73-0.84——
2022-11-07-0.93-0.80——
2022-08-08-0.80-0.69——
2022-05-09-0.68-0.56——
2022-02-28-0.54-0.46——
2021-11-10-0.51-0.47——
2021-08-11-0.46-0.46——
2021-05-11-0.41-0.41——
2021-03-29-0.41-0.48——
2020-11-12-0.41-0.42——
2020-08-12-1.72-1.27——
2020-06-15-3.69———
2020-03-31-6.70———
2019-09-30-2.93———
2019-06-30-2.90———
2019-03-31-3.72———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-05Wassil JimBuy18.00K$5.3596.30K
2026-10-05Wassil JimSell18.00K$86.741.56M
2026-10-05Wassil JimSell18.00K$5.3596.30K
2026-10-05Cowan ElviaSell19.00K$25.92492.48K
2026-10-05Cowan ElviaBuy19.00K$25.92492.48K
2026-10-05Cowan ElviaSell19.00K$86.741.65M
2026-10-01Wassil JimBuy2.25K$5.3512.04K
2026-10-01Wassil JimSell2.15K$56.65122.09K
2026-10-01Wassil JimSell95$57.095.42K
2026-10-01Wassil JimSell2.25K$5.3512.04K
2026-09-09Wassil JimSell1.33K$59.5279.40K
2026-09-08PICKERING GRANTSell17.06K$60.361.03M
2026-09-08GUGGENHIME ANDREWSell7.16K$60.36431.88K
2026-09-08Dhaliwal Harpreet S.Sell7.65K$60.36461.81K
2026-09-08Cowan ElviaSell1.33K$60.3680.10K
2026-09-08Wassil JimSell5.46K$60.36329.51K
2026-09-04Wassil JimSell1.38K$61.1684.46K
2026-09-04Jodar LuisBuy88.25K$61.165.40M
2026-09-04Jodar LuisBuy52.63K——
2026-09-02Wassil JimSell1.43K$61.5888.18K
2026-09-02PICKERING GRANTSell3.43K$61.58211.03K
2026-09-02GUGGENHIME ANDREWSell1.43K$61.5888.18K
2026-09-02Dhaliwal Harpreet S.Sell659$61.5840.58K
2026-09-02Cowan ElviaSell326$61.5820.08K
2026-09-01Wassil JimBuy2.25K$5.3512.04K
2026-09-01Wassil JimSell1.54K$60.8993.58K
2026-09-01Wassil JimSell713$61.4843.84K
2026-09-01Wassil JimSell924$60.9556.32K
2026-09-01Wassil JimSell303$61.4218.61K
2026-09-01Wassil JimSell2.25K$5.3512.04K
2026-08-31Jodar LuisOther23.94K$47.301.13M
2026-08-31Wassil JimSell1.27K$60.7477.32K
2026-08-31PICKERING GRANTSell2.86K$60.74173.84K
2026-08-31GUGGENHIME ANDREWSell1.27K$60.7477.32K
2026-08-31Dhaliwal Harpreet S.Sell361$60.7421.93K
2026-08-31Cowan ElviaSell243$60.7414.76K
2026-08-05Dhaliwal Harpreet S.Buy17.00K$24.79421.43K
2026-08-05Dhaliwal Harpreet S.Sell17.00K$55.00935.07K
2026-08-05Dhaliwal Harpreet S.Sell17.00K$24.79421.43K
2026-08-03Wassil JimBuy2.25K$5.3512.04K
2026-08-03Wassil JimSell861$53.5046.07K
2026-08-03Wassil JimSell1.39K$54.0975.13K
2026-08-03Wassil JimSell2.25K$5.3512.04K
2026-08-03GUGGENHIME ANDREWSell10.00K$5.3553.50K
2026-08-03GUGGENHIME ANDREWBuy10.00K$5.3553.50K
2026-08-03GUGGENHIME ANDREWSell6.96K$53.76373.96K
2026-08-03GUGGENHIME ANDREWSell3.04K$54.18164.92K
2026-07-27PICKERING GRANTBuy16.20K$2.0332.88K
2026-07-27PICKERING GRANTSell11.78K$55.52654.13K
2026-07-27PICKERING GRANTSell4.42K$55.93246.94K
2026-07-27PICKERING GRANTSell16.20K$2.0332.88K
2026-07-27PICKERING GRANTSell622$55.5434.55K
2026-07-27PICKERING GRANTSell756$55.5241.97K
2026-07-27PICKERING GRANTSell378$55.9121.14K
2026-07-27PICKERING GRANTSell244$55.9613.66K
2026-07-16Markels JohnBuy23.03K$56.041.29M
2026-07-16Markels JohnOther0——
2026-07-06GUGGENHIME ANDREWSell10.00K$5.3553.50K
2026-07-06GUGGENHIME ANDREWBuy10.00K$5.3553.50K
2026-07-06GUGGENHIME ANDREWSell7.91K$57.16452.28K
2026-07-06GUGGENHIME ANDREWSell2.09K$57.76120.55K
2026-07-01Wassil JimBuy516$5.352.76K
2026-07-01Wassil JimSell1.79K$56.03100.18K
2026-07-01Wassil JimSell456$57.4726.21K
2026-07-01Wassil JimSell6$57.82347
2026-07-01Wassil JimSell516$5.352.76K
2026-06-26PICKERING GRANTSell6.68K$54.27362.72K
2026-06-26PICKERING GRANTSell9.14K$55.27504.96K
2026-06-26PICKERING GRANTSell6.42K$56.12360.13K
2026-06-26PICKERING GRANTSell207$54.2211.22K
2026-06-26PICKERING GRANTSell312$54.3416.96K
2026-06-26PICKERING GRANTSell356$55.2319.66K
2026-06-26PICKERING GRANTSell602$55.3033.29K
2026-06-26PICKERING GRANTSell191$56.2710.75K
2026-06-26PICKERING GRANTSell332$55.9918.59K
2026-06-22Slaoui MoncefBuy26.06K$52.111.36M
2026-06-18PICKERING GRANTBuy225$1.79403
2026-06-18PICKERING GRANTSell225$52.5111.81K
2026-06-18PICKERING GRANTSell22.24K$52.501.17M
2026-06-18PICKERING GRANTSell1.00K$52.5052.50K
2026-06-18PICKERING GRANTSell225$1.79403
2026-06-18GUGGENHIME ANDREWSell10.00K$5.3553.50K
2026-06-18GUGGENHIME ANDREWBuy10.00K$5.3553.50K
2026-06-18GUGGENHIME ANDREWSell10.00K$53.00530.00K
2026-06-17Slaoui MoncefOther0——
2026-06-15Paya Carlos VBuy11.39K$49.56564.44K
2026-06-15Paya Carlos VBuy2.27K——
2026-06-15BRANDICOURT OLIVIERBuy11.03K$49.56546.85K
2026-06-15BRANDICOURT OLIVIERBuy2.19K——
2026-06-15Furey JohnBuy11.39K$49.56564.44K
2026-06-15Furey JohnBuy2.27K——
2026-06-15Lee JacksBuy11.39K$49.56564.44K
2026-06-15Lee JacksBuy2.27K——
2026-06-15Gilbert Halley EBuy2.27K——
2026-06-15Gilbert Halley EBuy11.39K$49.56564.44K
2026-06-15Loxam TeriBuy2.27K——
2026-06-15Loxam TeriBuy11.39K$49.56564.44K
2026-06-15Drapeau Anne SBuy2.27K——
2026-06-15Drapeau Anne SBuy11.39K$49.56564.44K
2026-06-15Lukatch HeathBuy2.27K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 351, holders 0 vs prior quarter. Ownership 116.62%.

HolderSharesChangeChange %Value
FMR LLC20.85M4.36M+26.44%1.21B
JUPITER TOPCO LLC17.97M17.97MNew1.04B
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.12.21M81.43K+0.67%709.62M
BLACKROCK, INC.12.07M1.10M+9.99%701.52M
RA CAPITAL MANAGEMENT, L.P.11.47M00.00%667.02M
WELLINGTON MANAGEMENT GROUP LLP7.00M1.39M+24.70%407.00M
VANGUARD PORTFOLIO MANAGEMENT LLC6.59M314.01K+5.00%383.28M
VANGUARD CAPITAL MANAGEMENT LLC6.35M81.98K+1.31%369.05M
STATE STREET CORP5.35M911.18K+20.52%311.09M
DEEP TRACK CAPITAL, LP4.30M00.00%249.96M
GEODE CAPITAL MANAGEMENT, LLC3.46M258.08K+8.06%201.13M
PRICE T ROWE ASSOCIATES INC /MD/2.99M2.01M+206.12%173.75M
KYNAM CAPITAL MANAGEMENT, LP2.92M00.00%169.88M
WESTFIELD CAPITAL MANAGEMENT CO LP2.47M-1.17M-32.19%143.72M
CALIGAN PARTNERS LP2.19M127.92K+6.21%127.23M
PARADIGM BIOCAPITAL ADVISORS LP2.13M-2.67M-55.61%123.69M
BELLEVUE GROUP AG1.97M781.24K+65.61%114.63M
D. E. SHAW & CO., INC.1.90M-963.45K-33.62%110.56M
MAVERICK CAPITAL LTD1.61M235.50K+17.09%93.78M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.46M60.86K+4.34%85.15M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.46M1.46MNew85.15M
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC1.43M53.05K+3.87%82.86M
EVENTIDE ASSET MANAGEMENT, LLC1.38M5.93K+0.43%80.23M
GOLDMAN SACHS GROUP INC1.35M75.72K+5.94%78.52M
NORTHERN TRUST CORP1.28M135.70K+11.86%74.42M

Earnings and financials

Vaxcyte, Inc. (PCVX) trades at $61.21, with a market cap of $9.63B and a trailing P/E of -7.85. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

201720182019202020212022202320242025
000000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Vaxcyte (PCVX) Financials: Revenue & Earnings

PCVX$61.21+0.54 +0.89%

$9.63B

Market Cap

-7.85

P/E

82.35

Forward P/E

68

Score

Price History